Daniel Francis DiToro, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Autoimmunity | 2 | 2024 | 1370 | 0.910 |
Why?
|
T-Lymphocytes, Helper-Inducer | 5 | 2024 | 975 | 0.760 |
Why?
|
Hemolysis | 1 | 2022 | 423 | 0.700 |
Why?
|
Potassium | 1 | 2022 | 1313 | 0.600 |
Why?
|
Receptor, IGF Type 1 | 1 | 2020 | 380 | 0.590 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2021 | 4353 | 0.580 |
Why?
|
Th17 Cells | 2 | 2020 | 787 | 0.550 |
Why?
|
Cell Lineage | 3 | 2021 | 2533 | 0.510 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1088 | 0.510 |
Why?
|
Lymphocytes | 1 | 2022 | 2611 | 0.480 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2020 | 828 | 0.470 |
Why?
|
Immunity, Innate | 2 | 2022 | 3047 | 0.430 |
Why?
|
Interleukin-2 | 1 | 2018 | 1889 | 0.380 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2250 | 0.380 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2020 | 2448 | 0.380 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2058 | 0.370 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2023 | 2536 | 0.360 |
Why?
|
Cell Differentiation | 5 | 2021 | 11481 | 0.320 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3844 | 0.310 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3075 | 0.270 |
Why?
|
Gene Expression | 1 | 2018 | 7588 | 0.260 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2023 | 65 | 0.200 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6853 | 0.190 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 223 | 0.190 |
Why?
|
Hematologic Tests | 1 | 2022 | 238 | 0.190 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 2021 | 58 | 0.180 |
Why?
|
Lymphocyte Activation | 4 | 2020 | 5496 | 0.170 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 226 | 0.160 |
Why?
|
Nasal Cavity | 1 | 2021 | 304 | 0.160 |
Why?
|
Nose Neoplasms | 1 | 2021 | 249 | 0.160 |
Why?
|
Laboratories | 1 | 2022 | 462 | 0.160 |
Why?
|
Mice, Transgenic | 4 | 2020 | 9530 | 0.160 |
Why?
|
Antigens | 1 | 2024 | 1447 | 0.150 |
Why?
|
Eosinophils | 1 | 2022 | 944 | 0.150 |
Why?
|
Skull Base Neoplasms | 1 | 2021 | 269 | 0.140 |
Why?
|
Status Epilepticus | 1 | 2023 | 456 | 0.140 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2021 | 547 | 0.140 |
Why?
|
Interleukin-6 | 2 | 2020 | 3215 | 0.130 |
Why?
|
B-Lymphocytes | 3 | 2024 | 4742 | 0.130 |
Why?
|
Osteosarcoma | 1 | 2021 | 897 | 0.120 |
Why?
|
Kinetics | 1 | 2022 | 6377 | 0.120 |
Why?
|
Genes, Reporter | 1 | 2018 | 1529 | 0.120 |
Why?
|
Germinal Center | 3 | 2011 | 379 | 0.110 |
Why?
|
Cell Communication | 1 | 2020 | 1653 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 1407 | 0.100 |
Why?
|
Colitis | 1 | 2020 | 1229 | 0.100 |
Why?
|
Immune Tolerance | 1 | 2020 | 2299 | 0.090 |
Why?
|
Transcription, Genetic | 2 | 2021 | 7593 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4550 | 0.080 |
Why?
|
Kidney Transplantation | 1 | 2023 | 4215 | 0.070 |
Why?
|
Mice, Inbred C57BL | 4 | 2020 | 22023 | 0.070 |
Why?
|
Animals | 8 | 2021 | 167963 | 0.070 |
Why?
|
Peptide Fragments | 1 | 2020 | 5125 | 0.070 |
Why?
|
Chromatin | 1 | 2018 | 2938 | 0.070 |
Why?
|
Interleukin-4 | 1 | 2010 | 1130 | 0.070 |
Why?
|
Mice | 6 | 2020 | 81208 | 0.070 |
Why?
|
Interleukins | 1 | 2011 | 785 | 0.070 |
Why?
|
Sepsis | 1 | 2019 | 2592 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8515 | 0.060 |
Why?
|
Immunity | 1 | 2011 | 998 | 0.060 |
Why?
|
Transcription Factors | 2 | 2018 | 12103 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11903 | 0.060 |
Why?
|
Phenotype | 1 | 2021 | 16546 | 0.050 |
Why?
|
Anterior Temporal Lobectomy | 1 | 2023 | 45 | 0.050 |
Why?
|
Signal Transduction | 4 | 2020 | 23376 | 0.050 |
Why?
|
Acyclovir | 1 | 2023 | 268 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2022 | 26181 | 0.050 |
Why?
|
T-Lymphocyte Subsets | 1 | 2009 | 1810 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2825 | 0.050 |
Why?
|
Prognosis | 1 | 2021 | 29658 | 0.050 |
Why?
|
Antigens, CD | 1 | 2010 | 4000 | 0.040 |
Why?
|
Clone Cells | 1 | 2023 | 1660 | 0.040 |
Why?
|
Humans | 9 | 2024 | 760621 | 0.040 |
Why?
|
Protective Agents | 1 | 2019 | 150 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1697 | 0.040 |
Why?
|
Probiotics | 1 | 2019 | 377 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2023 | 2005 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22072 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2019 | 2672 | 0.030 |
Why?
|
Age of Onset | 1 | 2019 | 3301 | 0.030 |
Why?
|
Colon | 1 | 2020 | 1788 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2009 | 9585 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2020 | 14372 | 0.020 |
Why?
|
Infant, Premature | 1 | 2019 | 2092 | 0.020 |
Why?
|
Seizures | 1 | 2023 | 2917 | 0.020 |
Why?
|
Graft Rejection | 1 | 2023 | 4426 | 0.020 |
Why?
|
Female | 4 | 2023 | 391270 | 0.020 |
Why?
|
Arenaviridae Infections | 1 | 2009 | 53 | 0.020 |
Why?
|
B-Lymphocyte Subsets | 1 | 2010 | 241 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2009 | 191 | 0.020 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2009 | 177 | 0.020 |
Why?
|
Plasma Cells | 1 | 2011 | 591 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7064 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5794 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2010 | 1342 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2010 | 1871 | 0.020 |
Why?
|
Male | 2 | 2020 | 359744 | 0.020 |
Why?
|
Antibody Formation | 1 | 2009 | 1400 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18137 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2873 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 58995 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 18957 | 0.010 |
Why?
|
Cytokines | 1 | 2009 | 7343 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2009 | 12766 | 0.010 |
Why?
|
Middle Aged | 1 | 2023 | 220352 | 0.000 |
Why?
|